| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 665535 | 72441 | ATORVASTATINA VIR PHARMA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA VIR PHARMA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72441/72441_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72441/72441_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2010-06-22 | 1 | 1 | 1 | 2010-06-22 | 2010-06-22 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 665536 | 72442 | ATORVASTATINA VIR PHARMA 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA VIR PHARMA 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72442/72442_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72442/72442_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2010-06-22 | 1 | 1 | 1 | 2010-06-22 | 2010-06-22 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 665537 | 72443 | ATORVASTATINA VIR PHARMA 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA VIR PHARMA 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72443/72443_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72443/72443_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2010-06-22 | 1 | 1 | 1 | 2010-06-22 | 2010-06-22 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 665541 | 72446 | VALSARTAN/HIDROCLOROTIAZIDA NORMON 80 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN/HIDROCLOROTIAZIDA NORMON 80 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 80 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72446/72446_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72446/72446_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-06-23 | 1 | 1 | 1 | 2019-01-28 | 2019-01-28 | 1 | 2011-02-21 | View Edit Delete | ||||||||||||
| 665542 | 72445 | VALSARTAN/HIDROCLOROTIAZIDA NORMON 160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN/HIDROCLOROTIAZIDA NORMON 160 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72445/72445_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72445/72445_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-06-23 | 1 | 1 | 1 | 2019-02-08 | 2019-02-08 | 1 | 2011-02-21 | View Edit Delete | ||||||||||||
| 665543 | 72444 | VALSARTAN/HIDROCLOROTIAZIDA NORMON 160 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN/HIDROCLOROTIAZIDA NORMON 160 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 160 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72444/72444_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72444/72444_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-06-23 | 1 | 1 | 1 | 2019-01-28 | 2019-01-28 | 1 | 2011-02-21 | View Edit Delete | ||||||||||||
| 665549 | 72463 | ESPINO ALBAR ARKOPHARMA cápsulas duras | ESPINO ALBAR ARKOPHARMA cápsulas duras , 48 cápsulas | 350 mg | 6 | 48 | 43 | 48 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72463/72463_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72463/72463_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 23799 | ARKOPHARMA LABORATORIOS S.A.U. | 2010-06-28 | 1 | 1 | 1 | 2010-06-28 | 2010-06-28 | 0 | 2011-04-25 | View Edit Delete | ||||||||||||
| 665550 | 72463 | ESPINO ALBAR ARKOPHARMA cápsulas duras | ESPINO ALBAR ARKOPHARMA cápsulas duras , 84 cápsulas | 350 mg | 6 | 84 | 43 | 84 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72463/72463_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72463/72463_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 23799 | ARKOPHARMA LABORATORIOS S.A.U. | 2010-06-28 | 1 | 1 | 1 | 2010-06-28 | 2010-06-28 | 0 | 2026-06-11 | View Edit Delete | ||||||||||||
| 665558 | 57273 | IOPAMIRO 300 mg/ml SOLUCION INYECTABLE | IOPAMIRO 300 mg/ml SOLUCION INYECTABLE , 1 frasco de 500 ml | 300 mg/ml | 6 | 1 | 48 | 1 frasco de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57273/57273_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57273/57273_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 9505 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 1987-09-01 | 1 | 1 | 1 | 1987-09-01 | 2010-06-24 | 1 | 2013-06-24 | View Edit Delete | ||||||||||||
| 665559 | 57272 | IOPAMIRO 370 mg/ml SOLUCION INYECTABLE | IOPAMIRO 370 mg/ml SOLUCION INYECTABLE , 1 frasco de 500 ml | 370 mg/ml | 6 | 1 | 48 | 1 frasco de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57272/57272_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57272/57272_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 9505 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 1987-09-01 | 1 | 1 | 1 | 1987-09-01 | 2010-06-24 | 1 | 2013-06-28 | View Edit Delete | ||||||||||||
| 665561 | 72532 | OMEPRAZOL NORMON 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL NORMON 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 14 cápsulas | 40 mg | 5 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72532/72532_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72532/72532_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-07-14 | 1 | 1 | 1 | 2010-07-14 | 2010-07-14 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 665562 | 61788 | TRIALONA 250 MICROGRAMOS/INHALACIÓN, SUSPENSIÓN PARA INHALACIÓN EN ENVASE A PRESIÓN | TRIALONA 250 MICROGRAMOS/INHALACIÓN, SUSPENSIÓN PARA INHALACIÓN EN ENVASE A PRESIÓN, 1 inhalador de 120 dosis | 250 microgramos/dosis | 12 | 120 | 30 | 1 inhalador de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61788/61788_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61788/61788_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1997-11-01 | 1 | 1 | 1 | 1997-11-01 | 1997-11-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665563 | 72532 | OMEPRAZOL NORMON 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL NORMON 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas | 40 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72532/72532_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72532/72532_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-07-14 | 1 | 1 | 1 | 2010-07-14 | 2010-07-14 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 665566 | 72565 | PANTOPRAZOL QUALIGEN 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL QUALIGEN 20 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos (BLISTER) | 20 mg | 5 | 28 | 10 | 28 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72565/72565_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72565/72565_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2010-07-22 | 1 | 1 | 1 | 2010-07-22 | 2010-07-22 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665567 | 72399 | TRAMADOL VIR 100 mg/ml GOTAS ORALES EN SOLUCION EFG | TRAMADOL VIR 100 mg/ml GOTAS ORALES EN SOLUCION EFG , 1 frasco de 30 ml | 100 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72399/72399_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72399/72399_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2010-06-14 | 1 | 1 | 1 | 2010-06-14 | 2010-07-09 | 1 | 2013-10-16 | View Edit Delete | ||||||||||||
| 665570 | 61787 | TRIALONA 50 MICROGRAMOS/INHALACIÓN, SUSPENSIÓN PARA INHALACIÓN EN ENVASE A PRESIÓN | TRIALONA 50 MICROGRAMOS/INHALACIÓN, SUSPENSIÓN PARA INHALACIÓN EN ENVASE A PRESIÓN, 1 inhalador de 120 dosis | 50 microgramos/dosis | 12 | 120 | 30 | 1 inhalador de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61787/61787_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61787/61787_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1997-11-01 | 1 | 1 | 1 | 1997-11-01 | 1997-11-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665588 | 61786 | ADOLONTA RETARD 200 mg COMPRIMIDOS DE LIBERACION PROLONGADA | ADOLONTA RETARD 200 mg COMPRIMIDOS DE LIBERACION PROLONGADA, 20 comprimidos | 200 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61786/61786_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61786/61786_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | GRÜNENTHAL PHARMA S.A. | 1998-03-01 | 1 | 1 | 1 | 1998-03-01 | 1998-03-01 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 665589 | 69635 | QUETIAPINA KERN PHARMA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | QUETIAPINA KERN PHARMA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 25 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69635/69635_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69635/69635_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2008-02-22 | 1 | 1 | 1 | 2008-02-22 | 2010-06-29 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 665596 | 61785 | ADOLONTA RETARD 150 mg COMPRIMIDOS DE LIBERACION PROLONGADA | ADOLONTA RETARD 150 mg COMPRIMIDOS DE LIBERACION PROLONGADA, 20 comprimidos | 150 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61785/61785_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61785/61785_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10103 | GRÜNENTHAL PHARMA S.A. | 1998-03-01 | 1 | 1 | 1 | 1998-03-01 | 1998-03-01 | 1 | 2011-10-13 | View Edit Delete | ||||||||||||
| 665603 | 71393 | LERCANIDIPINO VIATRIS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LERCANIDIPINO VIATRIS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71393/71393_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71393/71393_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L. | 2010-07-09 | 1 | 1 | 1 | 2010-07-09 | 2010-07-09 | 1 | 2011-02-24 | View Edit Delete |
Page 226 of 1035, showing 20 records out of 20697 total, starting on record 4501, ending on 4520